Significant expansion of the donor pool achieved by utilizing islets of variable quality in the production of allogeneic "Neo-Islets", 3-D organoids of Mesenchymal Stromal and islet cells, a novel immune-isolating biotherapy for Type I Diabetes.

通过利用质量参差不齐的胰岛生产同种异体“新胰岛”，即间充质基质细胞和胰岛细胞的三维类器官，从而显著扩大了供体库，这是一种用于治疗 I 型糖尿病的新型免疫隔离生物疗法